ArticleScientific reports2026
Chitosan and polycaprolactone blended PDMS coatings improve biocompatibility of magnetic elastomers.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
PDMS/NdFeB composites are promising materials for soft magnetic actuators, but NdFeB particles corrode in body fluids and release toxic metal ions, limiting their biomedical use. We developed ~ 100 µm spin-coated PDMS-chitosan (PDMS-CHIT) and PDMS-polycaprolactone (PDMS-PCL) coatings that solve this problem. Over 24 weeks of immersion, these coatings reduced neodymium and iron release by more than 95%, keeping ion concentrations well below cytotoxicity thresholds. Importantly, the PDMS-PCL coating fully preserved magnetorheological actuation (ΔG' ≈ 61 kPa under 0.5 T, comparable to uncoated composite), while PDMS-CHIT provided superior ion barrier at the cost of reduced actuation force. Biological validation confirmed cytocompatibility with fibroblasts, hemocompatibility with erythrocytes, and strong suppression of bacterial biofilm formation. These results establish a validated materials platform for biocompatible soft magnetic actuators.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.